In Situ Generation of Pyroptosis Inducer Mediated by Intracellular Labile Copper Pool for Safe and Robust Antitumor Immunotherapy

IF 16 1区 材料科学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Yanjie Zhang, Lu Zhang, Mengyu Sun, Fang Pu*, Wenjie Wang, Anjun Song, Jinsong Ren* and Xiaogang Qu*, 
{"title":"In Situ Generation of Pyroptosis Inducer Mediated by Intracellular Labile Copper Pool for Safe and Robust Antitumor Immunotherapy","authors":"Yanjie Zhang,&nbsp;Lu Zhang,&nbsp;Mengyu Sun,&nbsp;Fang Pu*,&nbsp;Wenjie Wang,&nbsp;Anjun Song,&nbsp;Jinsong Ren* and Xiaogang Qu*,&nbsp;","doi":"10.1021/acsnano.4c1532410.1021/acsnano.4c15324","DOIUrl":null,"url":null,"abstract":"<p >Pyroptosis has garnered increasing interest in the realm of cancer immunotherapy. Utilizing reactive oxygen species (ROS) to trigger oxidative stress is considered an effective strategy for promoting pyroptosis. However, existing catalytic nanoparticles used as pyroptosis inducers contain heavy metals, which inevitably cause potential side effects on normal tissues due to their high toxicity and off-target effects. Herein, a labile copper pool-mediated in situ pyroptosis inducer was designed and developed using a hydrogen-bonded organic framework (HOF)-based nanoplatform to achieve safe and robust antitumor immunotherapy. The nanoplatform could target mitochondria and elevate labile Cu<sup>2+</sup> levels in cells, implementing the in situ synthesis of a pyroptosis inducer through the formation of catalytic nanoparticles with peroxidase (POD) and superoxide dismutase (SOD)-mimicking activities. Our results confirmed that the nanoplatform could generate high levels of ROS, resulting in pyroptotic cell death. When combined with antiprogrammed death receptor 1 therapy (αPD-1), the pyroptosis inducer exhibited excellent antitumor capacity in tumor models. Meanwhile, it exhibited minimal toxicity to healthy tissues due to the low intracellular copper concentration in normal cells. Overall, our work provides potential for the development of efficient and safe antitumor immunotherapy.</p>","PeriodicalId":21,"journal":{"name":"ACS Nano","volume":"19 19","pages":"18129–18142 18129–18142"},"PeriodicalIF":16.0000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Nano","FirstCategoryId":"88","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsnano.4c15324","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Pyroptosis has garnered increasing interest in the realm of cancer immunotherapy. Utilizing reactive oxygen species (ROS) to trigger oxidative stress is considered an effective strategy for promoting pyroptosis. However, existing catalytic nanoparticles used as pyroptosis inducers contain heavy metals, which inevitably cause potential side effects on normal tissues due to their high toxicity and off-target effects. Herein, a labile copper pool-mediated in situ pyroptosis inducer was designed and developed using a hydrogen-bonded organic framework (HOF)-based nanoplatform to achieve safe and robust antitumor immunotherapy. The nanoplatform could target mitochondria and elevate labile Cu2+ levels in cells, implementing the in situ synthesis of a pyroptosis inducer through the formation of catalytic nanoparticles with peroxidase (POD) and superoxide dismutase (SOD)-mimicking activities. Our results confirmed that the nanoplatform could generate high levels of ROS, resulting in pyroptotic cell death. When combined with antiprogrammed death receptor 1 therapy (αPD-1), the pyroptosis inducer exhibited excellent antitumor capacity in tumor models. Meanwhile, it exhibited minimal toxicity to healthy tissues due to the low intracellular copper concentration in normal cells. Overall, our work provides potential for the development of efficient and safe antitumor immunotherapy.

Abstract Image

细胞内不稳定铜池介导的焦亡诱导剂的原位生成用于安全可靠的抗肿瘤免疫治疗
焦亡在癌症免疫治疗领域引起了越来越多的兴趣。利用活性氧(ROS)触发氧化应激被认为是促进焦亡的有效策略。然而,现有的用作焦亡诱导剂的催化纳米颗粒含有重金属,由于其高毒性和脱靶效应,不可避免地对正常组织产生潜在的副作用。本文利用氢键有机框架(HOF)纳米平台设计并开发了一种稳定的铜池介导的原位焦亡诱导剂,以实现安全可靠的抗肿瘤免疫治疗。该纳米平台可以靶向线粒体,提高细胞中不稳定的Cu2+水平,通过形成具有过氧化物酶(POD)和超氧化物歧化酶(SOD)模拟活性的催化纳米颗粒,实现焦亡诱导剂的原位合成。我们的研究结果证实,纳米平台可以产生高水平的活性氧,导致热噬细胞死亡。当与抗程序性死亡受体1治疗(αPD-1)联合使用时,焦亡诱导剂在肿瘤模型中表现出良好的抗肿瘤能力。同时,由于正常细胞内铜浓度低,对健康组织的毒性很小。总之,我们的工作为开发高效、安全的抗肿瘤免疫疗法提供了潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Nano
ACS Nano 工程技术-材料科学:综合
CiteScore
26.00
自引率
4.10%
发文量
1627
审稿时长
1.7 months
期刊介绍: ACS Nano, published monthly, serves as an international forum for comprehensive articles on nanoscience and nanotechnology research at the intersections of chemistry, biology, materials science, physics, and engineering. The journal fosters communication among scientists in these communities, facilitating collaboration, new research opportunities, and advancements through discoveries. ACS Nano covers synthesis, assembly, characterization, theory, and simulation of nanostructures, nanobiotechnology, nanofabrication, methods and tools for nanoscience and nanotechnology, and self- and directed-assembly. Alongside original research articles, it offers thorough reviews, perspectives on cutting-edge research, and discussions envisioning the future of nanoscience and nanotechnology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信